<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36801857</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2542-5641</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Chinese medical journal</Title><ISOAbbreviation>Chin Med J (Engl)</ISOAbbreviation></Journal><ArticleTitle>Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations.</ArticleTitle><Pagination><StartPage>176</StartPage><EndPage>183</EndPage><MedlinePgn>176-183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CM9.0000000000002495</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Juvenile amyotrophic lateral sclerosis (JALS) is an uncommon form of amyotrophic lateral sclerosis whose age at onset (AAO) is defined as prior to 25 years. FUS mutations are the most common cause of JALS. SPTLC1 was recently identified as a disease-causative gene for JALS, which has rarely been reported in Asian populations. Little is known regarding the difference in clinical features between JALS patients carrying FUS and SPTLC1 mutations. This study aimed to screen mutations in JALS patients and to compare the clinical features between JALS patients with FUS and SPTLC1 mutations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixteen JALS patients were enrolled, including three newly recruited patients between July 2015 and August 2018 from the Second Affiliated Hospital, Zhejiang University School of Medicine. Mutations were screened by whole-exome sequencing. In addition, clinical features such as AAO, onset site and disease duration were extracted and compared between JALS patients carrying FUS and SPTLC1 mutations through a literature review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A novel and de novo SPTLC1 mutation (c.58G&gt;A, p.A20T) was identified in a sporadic patient. Among 16 JALS patients, 7/16 carried FUS mutations and 5/16 carried respective SPTLC1 , SETX , NEFH , DCTN1 , and TARDBP mutations. Compared with FUS mutation patients, those with SPTLC1 mutations had an earlier AAO (7.9&#x200a;&#xb1;&#x200a;4.6 years vs. 18.1&#x200a;&#xb1;&#x200a;3.9 years, P &#x200a;&lt;&#x200a;0.01), much longer disease duration (512.0 [416.7-607.3] months vs. 33.4 [21.6-45.1] months, P &#x200a;&lt;&#x200a;0.01), and no onset of bulbar.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings expand the genetic and phenotypic spectrum of JALS and help to better understand the genotype-phenotype correlation of JALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Peishan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Medical Neurobiology of Zhejiang Province, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Medical Neurobiology of Zhejiang Province, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongfu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Medical Neurobiology of Zhejiang Province, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhi-Ying</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, and Key Laboratory of Medical Neurobiology of Zhejiang Province, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Med J (Engl)</MedlineTA><NlmUniqueID>7513795</NlmUniqueID><ISSNLinking>0366-6999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="D051102">Serine C-Palmitoyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C484368">SETX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="C487784">SPTLC1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="N">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051102" MajorTopicYN="N">Serine C-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>21</Day><Hour>16</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36801857</ArticleId><ArticleId IdType="pmc">PMC10106144</ArticleId><ArticleId IdType="doi">10.1097/CM9.0000000000002495</ArticleId><ArticleId IdType="pii">00029330-202301200-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. . Amyotrophic lateral sclerosis. Lancet 2017; 390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Orban P, Devon RS, Hayden MR, Leavitt BR. Chapter 15 juvenile amyotrophic lateral sclerosis. Handb Clin Neurol 2007; 82:301&#x2013;312. doi: 10.1016/S0072-9752(07)80018-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">18808900</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehky T, Grunseich C. Juvenile amyotrophic lateral sclerosis: a review. Genes 2021; 12:1935.doi: 10.3390/genes12121935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8701111</ArticleId><ArticleId IdType="pubmed">34946884</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslow DK, Weissman JS. Membranes in balance: mechanisms of sphingolipid homeostasis. Mol Cell 2010; 40:267&#x2013;279. doi: 10.1016/j.molcel.2010.10.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2987644</ArticleId><ArticleId IdType="pubmed">20965421</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 2001; 27:309&#x2013;312. doi: 10.1038/85879.</Citation><ArticleIdList><ArticleId IdType="pubmed">11242114</ArticleId></ArticleIdList></Reference><Reference><Citation>Penno A, Reilly MM, Houlden H, Laur&#xe1; M, Rentsch K, Niederkofler V, et al. . Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 2010; 285:11178&#x2013;11187. doi: 10.1074/jbc.M109.092973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856995</ArticleId><ArticleId IdType="pubmed">20097765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P, Donkervoort S, Lone MA, Nalls M, Gable K, Gupta SD, et al. . Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat Med 2021; 27:1197&#x2013;1204. doi: 10.1038/s41591-021-01346-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Chia R, Miller DE, Li R, Kumaran R, Abramzon Y, et al. . Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis. JAMA Neurol 2021; 78:1236&#x2013;1248. doi: 10.1001/jamaneurol.2021.2598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406220</ArticleId><ArticleId IdType="pubmed">34459874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone MA, Zeng S, Bourquin F, Wang M, Huang S, Lin Z, et al. . SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS. medRxiv 2022; doi: 10.1101/2022.02.07.22269609.</Citation></Reference><Reference><Citation>H&#xfc;bers A, Just W, Rosenbohm A, M&#xfc;ller K, Marroquin N, Goebel I, et al. . De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol Aging 2015; 36:3117.e1&#x2013;3117.e6. doi: 10.1016/j.neurobiolaging.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">26362943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Liu GL, Tao QQ, Ni W, Xiao BG, et al. . The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet 2017; 92:267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, Zhang QJ, Chen CX, Tao QQ, et al. . Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis 2019; 10:1199&#x2013;1206. doi: 10.14336/AD.2019.0215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844596</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. . A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Peikert K, G&#xfc;nther R, van der Kooi AJ, Aronica E, H&#xfc;bers A, et al. . Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2019; 6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Rev Neurol 2021; 177:333&#x2013;340. doi: 10.1016/j.neurol.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">33036763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu MS, Li XG, Cui LY. Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener 2016; 17:249&#x2013;252. doi: 10.3109/21678421.2016.1143012.</Citation><ArticleIdList><ArticleId IdType="pubmed">26972116</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G, Gupta SD, Gable K, Bacikova D, Sengupta N, Somashekarappa N, et al. . The ORMs interact with transmembrane domain 1 of Lcb1 and regulate serine palmitoyltransferase oligomerization, activity and localization. Biochim Biophys Acta Mol Cell Biol Lipids 2019; 1864:245&#x2013;259. doi: 10.1016/j.bbalip.2018.11.007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373489</ArticleId><ArticleId IdType="pubmed">30529276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J, Safer A, W&#xf6;hrle JC, Palm F, Nix WA, Maschke M, et al. . Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis-data from a population-based registry. J Neurol Sci 2014; 345:164&#x2013;167. doi: 10.1016/j.jns.2014.07.033.</Citation><ArticleIdList><ArticleId IdType="pubmed">25086855</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Zhao Z, Shen H, Bing Q, Li N, Hu J. Clinical and genetic features of patients with juvenile amyotrophic lateral sclerosis with Fused in Sarcoma (FUS) mutation. Med Sci Monit 2018; 24:8750&#x2013;8757. doi: 10.12659/MSM.913724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289031</ArticleId><ArticleId IdType="pubmed">30507891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Cui LY, Sun Q, Li XG, Liu MS, Xu Y, et al. . De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol Aging 2013; 34:e1&#x2013;8. doi: 10.1016/j.neurobiolaging.2012.09.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">23046859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Wang H, Cai Y, Wen H, Wang L, Zhu M, et al. . FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav 2020; 10:e01625.doi: 10.1002/brb3.1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303404</ArticleId><ArticleId IdType="pubmed">32307925</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li C, Yang T, Lin J, Shang H. A case of juvenile-onset amyotrophic lateral sclerosis with a de novo frameshift FUS gene mutation presenting with bilateral abducens palsy. Amyotroph Lateral Scler Frontotemporal Degener 2022; 23:313&#x2013;314. doi: 10.1080/21678421.2021.1927100.</Citation><ArticleIdList><ArticleId IdType="pubmed">34074186</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Wu W, Xie Z, Gang Q, Yu M, Liu J, et al. . Novel and recurrent mutations in a cohort of Chinese patients with young-onset amyotrophic lateral sclerosis. Front Neurosci 2019; 13:1289.doi: 10.3389/fnins.2019.01289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6908997</ArticleId><ArticleId IdType="pubmed">31866807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li J, Lu H, Liu Y. A de novo c.1509dupA:p R503fs mutation of FUS: report of a girl with sporadic juvenile amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2020; 21:635&#x2013;637. doi: 10.1080/21678421.2020.1775256.</Citation><ArticleIdList><ArticleId IdType="pubmed">32501131</ArticleId></ArticleIdList></Reference><Reference><Citation>Eura N, Sugie K, Suzuki N, Kiriyama T, Izumi T, Shimakura N, et al. . A juvenile sporadic amyotrophic lateral sclerosis case with P525L mutation in the FUS gene: a rare co-occurrence of autism spectrum disorder and tremor. J Neurol Sci 2019; 398:67&#x2013;68. doi: 10.1016/j.jns.2019.01.032.</Citation><ArticleIdList><ArticleId IdType="pubmed">30684766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikiami R, Yamakado H, Tatsumi S, Ayaki T, Hashi Y, Yamashita H, et al. . Amyotrophic lateral sclerosis after receiving the human papilloma virus vaccine: a case report of a 15-year-old girl. Intern Med 2018; 57:1917&#x2013;1919. doi: 10.2169/internalmedicine.0285-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064690</ArticleId><ArticleId IdType="pubmed">29434138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayanagi K, Sato M, Furuta N, Makioka K, Ikeda Y. Juvenile-onset sporadic amyotrophic lateral sclerosis with a frameshift FUS gene mutation presenting unique neuroradiological findings and cognitive impairment. Intern Med 2016; 55:689&#x2013;693. doi: 10.2169/internalmedicine.55.5569.</Citation><ArticleIdList><ArticleId IdType="pubmed">26984092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Mori A, Sakaguchi H, Suga T, Ishihara D, Ueda A, et al. . Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation. J Neurol 2012; 259:1039&#x2013;1044. doi: 10.1007/s00415-011-6292-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22057404</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, Webber A, Gan-Or Z, Moore F, Dagher A, Dion PA, et al. . De novo FUS P525L mutation in juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol Genet 2016; 2:e63.doi: 10.1212/NXG.0000000000000063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830191</ArticleId><ArticleId IdType="pubmed">27123482</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Langlais JS, Daoud H, Dion PA, Brais B, Rouleau GA. Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. Arch Neurol 2012; 69:653&#x2013;656. doi: 10.1001/archneurol.2011.2499.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248478</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Brunet F, Dupr&#xe9; N, Chrestian N. The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature. J Child Neurol 2020; 35:556&#x2013;562. doi: 10.1177/0883073820915099.</Citation><ArticleIdList><ArticleId IdType="pubmed">32281455</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S, Neumann M, Rosenbohm A, Birve A, Volk AE, Weishaupt JH, et al. . Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany. Eur J Neurol 2013; 20:540&#x2013;546. doi: 10.1111/ene.12031.</Citation><ArticleIdList><ArticleId IdType="pubmed">23217123</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A, Lattante S, Zollino M, Marangi G, Luigetti M, Del Grande A, et al. . P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul Disord 2012; 22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanteri P, Meola I, Canosa A, De Marco G, Lomartire A, Rinaudo MT, et al. . The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment. Neurobiol Aging 2021; 103:e1&#x2013;130. e7. doi: 10.1016/j.neurobiolaging.2021.01.029.</Citation><ArticleIdList><ArticleId IdType="pubmed">33637330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodur M, Toker RT, Ba&#x15f;ak AN, Okan MS. A rare case of juvenile amyotrophic lateral sclerosis. Turk J Pediatr 2021; 63:495&#x2013;499. doi: 10.24953/turkjped.2021.03.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">34254495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd KC, Power R, Ealing J, Hamdalla H. FUS-ALS presenting with myoclonic jerks in a 17-year-old man. Amyotroph Lateral Scler Frontotemporal Degener 2019; 20:278&#x2013;280. doi: 10.1080/21678421.2019.1582665.</Citation><ArticleIdList><ArticleId IdType="pubmed">30879340</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, et al. . Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 2010; 75:611&#x2013;618. doi: 10.1212/WNL.0b013e3181ed9cde.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2931770</ArticleId><ArticleId IdType="pubmed">20668261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, et al. . Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2010; 67:455&#x2013;461. doi: 10.1001/archneurol.2010.52.</Citation><ArticleIdList><ArticleId IdType="pubmed">20385912</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, et al. . De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat 2010; 31:E1377&#x2013;E1389. doi: 10.1002/humu.21241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, et al. . Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol 2010; 20:1069&#x2013;1076. doi: 10.1111/j.1750-3639.2010.00413.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951498</ArticleId><ArticleId IdType="pubmed">20579074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>